Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
this report recommended that the NIH reinstate and expand a requirement that pharmaceutical companies set reasonable prices for new prescription drugs developed with taxpayer support.
- Simplified Text
-
Report recommended NIH reinstate requirement that pharmaceutical companies set reasonable prices for taxpayer-supported drugs.
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- Op-Ed
- Context Details
-
{ "committee": "HELP Committee", "organization": "National Institutes of Health (NIH)" } - Subject Tags
- UUID
- 9fdb2e88-a280-4a0a-81e5-2f486f4ec05f
- Vector Index
- ✗ No vector
- Created
- September 12, 2025 at 12:34 AM (20 hours ago)
- Last Updated
- September 12, 2025 at 12:34 AM (20 hours ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
44
claims
🔥
20 hours ago
https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/
Senator Sanders criticizes exorbitant prescription drug prices in the US, highlighting the industry's lobbying power and advocating for price controls.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.